AAAAAA

   
Results: 1-10 |
Results: 10
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease
Authors: Imbimbo, BP
Citation: Bp. Imbimbo, Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease, CNS DRUGS, 15(5), 2001, pp. 375-390
Central acetylcholinesterase inhibition in Alzheimer patients
Authors: Imbimbo, BP
Citation: Bp. Imbimbo, Central acetylcholinesterase inhibition in Alzheimer patients, ANN NEUROL, 49(3), 2001, pp. 416-416
A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease
Authors: Imbimbo, BP Troetel, WM Martelli, P Lucchelli, F
Citation: Bp. Imbimbo et al., A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease, DEMENT G C, 11(1), 2000, pp. 17-24
Hemodynamic effects of MF 10058, a new cardioselective muscarinic M-2 receptor antagonist, in conscious dogs
Authors: Lamperti, G Champeroux, P Martel, E Colibretti, ML Santoro, L Imbimbo, BP
Citation: G. Lamperti et al., Hemodynamic effects of MF 10058, a new cardioselective muscarinic M-2 receptor antagonist, in conscious dogs, EUR J PHARM, 406(1), 2000, pp. 93-98
Synthesis of new cardioselective M-2 muscarinic receptor antagonists
Authors: Mandelli, GR Maiorana, S Terni, P Lamperti, G Colibretti, ML Imbimbo, BP
Citation: Gr. Mandelli et al., Synthesis of new cardioselective M-2 muscarinic receptor antagonists, CHEM PHARM, 48(11), 2000, pp. 1611-1622
Two-year treatment of Alzheimer's disease with eptastigmine
Authors: Imbimbo, BP Verdelli, G Martelli, P Marchesini, D
Citation: Bp. Imbimbo et al., Two-year treatment of Alzheimer's disease with eptastigmine, DEMENT G C, 10(2), 1999, pp. 139-147
Suicide in two patients with a diagnosis of probable Alzheimer disease
Authors: Ferris, SH Hofeldt, GT Carbone, G Masciandaro, P Troetel, WM Imbimbo, BP
Citation: Sh. Ferris et al., Suicide in two patients with a diagnosis of probable Alzheimer disease, ALZ DIS A D, 13(2), 1999, pp. 88-90
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease
Authors: Imbimbo, BP Martelli, P Troetel, WM Lucchelli, F Lucca, U Thal, LJ
Citation: Bp. Imbimbo et al., Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease, NEUROLOGY, 52(4), 1999, pp. 700-708
Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer
Authors: Kaisary, AV Bowsher, WG Gillatt, DA Anderson, JB Malone, PR Imbimbo, BP
Citation: Av. Kaisary et al., Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer, J UROL, 162(6), 1999, pp. 2019-2023
Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment
Authors: Imbimbo, BP Nicoli, M Martini, C Tomelleri, GP Martelli, P Ferrari, GP Gambina, G
Citation: Bp. Imbimbo et al., Acetylcholinesterase assay may predict cognitive response of Alzheimer patients to eptastigmine treatment, EUR J CL PH, 54(9-10), 1998, pp. 809-810
Risultati: 1-10 |